Overview
Help protect the future of infant health. We are currently enrolling healthy infants for a specialized pneumonia vaccine (PCV) research study. This is a great opportunity to support pediatric science while receiving expert-led care at no cost to you. To be eligible, babies should not have started their routine infant vaccine series yet.
Join our infant vaccine clinical trial by signing up below!
About the Study
Pneumococcal disease is caused by Streptococcus pneumoniae bacteria. It can cause various infections, including:
- Otitis media (a middle ear infection)
- Pneumonia (a lung infection)
- Bacteremia (a blood infection)
- Meningitis (an infection of the lining of the brain and spinal cord)
- Sinusitis (a sinus infection)
Babies are especially vulnerable to pneumococcal disease because their immune systems are still developing. Getting your baby vaccinated is the best way to help prevent pneumococcal disease.
Join our Infant Vaccine Clinical Trial
Ensuring your baby has a healthy start is a top priority, and you don’t have to navigate these early healthcare decisions alone. If you are looking for advanced ways to support your infant’s wellness, new research study options are available to provide access to potential next-generation vaccine options. Join our study today!
Why You Should Join
The vaccines available today defend against many types (strains) of pneumococcal bacteria, but they don’t protect against all. This means that while current vaccines are safe and effective, there is still a risk for children to get sick from strains that are not covered by existing immunizations.
This infant vaccine clinical trial is researching if an investigational formulation of a pneumococcal vaccine can help protect against more strains.
Why Your Participation Matters
By joining our study, you play a key role in advancing pediatric science. You’ll receive study-related investigational care from local experts and help develop better ways to protect infants from serious illness for years to reach.
Who Can Join
To qualify for our infant vaccine clinical trial, your child must:
- Be between 2 and 6 months old
- Be generally healthy, based on medical history and a physical exam
- Have not received pneumonia or pneumococcal vaccines
- Have not received routine baby shots (DTaP, Polio, Hib, Rotavirus)
- Exception: One (1) Hepatitis B shot in the first 30 days is allowed
- Have no major birth defects, chronic illnesses, or serious infections
*Other criteria may apply.
Not sure if you qualify? That’s okay.
A member of our recruitment team will review your medical history and medications with you to see if this infant vaccine clinical trial may be right for you.
You may also qualify for other studies.
What to Expect
If this infant vaccine clinical trial is a good fit for your little one, here’s what you can expect:
Study Duration
Participation lasts about a year and a half.
Study Visits
Includes [6] in-person visits and [1] phone call with the study team. 4 of these visits can take place during well-baby visits.
Compensation
There is no cost to participate, and health insurance is not required. You will also be paid for completing some study-related activities.
Procedures during the Study
- Babies enrolled in this study will be assigned by chance (like flipping a coin) to receive either the study vaccine or an approved pneumococcal vaccine called Prevnar 20®.
- Your baby will receive 4 vaccine doses over about 1 year. The doses will be given at 2, 4, 6, and 12-15 months of age in line with the schedule currently recommended for childhood pneumococcal vaccination.
Join our infant vaccine clinical trial now!
